Tele: 561.316.3330
Breaking Medical Device News

Tuesday, October 19, 2021
HomeEXECUTIVESDr. Timothy Deer joins PainTEQ Scientific Advisory Board

Dr. Timothy Deer joins PainTEQ Scientific Advisory Board

March 40, 2021

Dr. Timothy Deer, MD, DABPM is president and CEO of The Spine & Nerve Centers in Charleston, West Virginia.

PainTEQ is the creator of LinQ (pronounced “link”), a minimally invasive therapy for sacroiliac (SI) joint dysfunction.

With extensive experience in interventional pain management and a clinical professor of anesthesiology at West Virginia University, Deer brings both clinical and institutional knowledge of pain management. Dr. Timothy Deer is president emeritus of the West Virginia Society of Interventional Pain Physicians (WVSIPP) and past president of the International Neuromodulation Society (INS). Dr. Deer is also a former member of the board of directors of the American Society of Interventional Pain Physicians (ASIPP).

“PainTEQ’s LinQ system has changed the way we treat SI joint dysfunction. This posterior approach is the safest, and I’ve seen many suffering patients experience relief immediately,” said Dr. Timothy Deer. “I’m thrilled to work alongside a group of innovators to help make LinQ more accessible across the country and help launch a comprehensive medical education program to train physicians with LinQ.”

Dr. Deer is known for extensive research published in scientific journals and online resources with topics ranging from minimally invasive disc procedures to spinal cord and peripheral nerve stimulation. Dr. Deer also works to educate government officials on safe use of pain therapies and expanding access to care.

“Dr. Deer’s expansive knowledge and understanding of unique conditions and approaches make him an ideal fit for the Scientific Advisory Board,” said PainTEQ CEO, Sean LaNeve. “We continue to realize our goal of bringing the best-of-the-best onto the PainTEQ team.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

HistoSonics Receives FDA “Breakthrough Device Designation” for Novel Sonic Beam Therapy

Histotripsy of the liver provides clinicians the first automated external beam therapy using acoustic energy to mechanically destroy and liquefy tissue in the liver without incisions, ionizing radiation or heat.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Endolumik Inc. of Morgantown Secures $175,000 Angel Investment from Country Roads Angel Network

Endolumik, Inc. was founded in May 2020 by Mara McFadden, chief executive officer, and Dr. Nova Szoka, inventor of the surgical device.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced...

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

By using this website you agree to accept Medical Device News Magazine Privacy Policy